I’m obsessed with building great companies and focus on those life sciences that will affect humanity.
Early in my career, I was fortunate enough to help scale Ambature, a materials science company in the field of superconductivity. When I started Ambature, I didn’t have any experience in materials science; nevertheless, I operated under the belief that the inventor’s idea was right. Fast forward a few years, by the time I left my role, we created over 200 patents with more than 3,700 unique claims, accounting for more than half patents in the field of superconductivity.
After I left Ambature, I wanted to make a more significant impact in life sciences, and ultimately on humanity. Being driven by this social mission, I thought about starting a few companies simultaneously; however, after some back and forth, I ultimately concluded that starting a fund would better allow me to scale my efforts.
Through Zoic Capital, my team and I help our portfolio companies and investors:
► Develop large scale inclusive IP development strategy
► Help connect and codevelop deals with potential strategic acquirers
We are currently the only US-based venture firm focused solely on investing in the seed stage of Medtech, we go through a rigorous vetting process with each investment opportunity to ensure that:
1. their technological developments represent at least a 10X improvement in the standard of care
2. their technology relies upon scientific mechanisms which are fully supported by published literature, independent trials, and personal observation
3. in most cases, they have unique hardware and IP coupled with unique software
4. the leadership team has the necessary combination of vision and experience to create a transformational company
5. has an initial regulatory approval on a short timeline, typically two to four years
If you want to learn more about Zoic, the types of companies we invest in, or if you’d like to talk about the market and feature on my podcast, feel free to get in touch with me via email: neal@zoiccapital.com
If you know of an interesting deal for Zoic to look at, feel free to get in touch with my team here: deals@zoiccapital.com
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
ProbiusDx | Board Observer | Dec 1, 2020 | — | Detail |
Creative Destruction Lab (CDL) | Associate | — | — | Detail |